Home / What’s new? / Patents

Patents


Patent

Novel sulfonamidocarboxamide compounds as NLRP3 inhibitors and their preparation

Number
WO 2019/008025 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg
Patent

NOVEL UREA 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Number
WO 2020/089456 A1WO 2020/089459 A1
Year
2020
Customer
AiCuris
Site
Nijmegen
Department
Discovery
MCS People
Jasper Springer
Patent

NOVEL UREA 6,7-DIHYDRO-4H-PYRAZOLO[4,3-C]PYRIDINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Number
WO 2020/089452 A1
Year
2020
Customer
AiCuris
Site
Nijmegen
Department
Discovery
MCS People
Jasper Springer
Patent

NOVEL UREA 6,7-DIHYDRO-4H-THIAZOLO[5,4-C]PYRIDINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Number
WO 2020/089460 A1
Year
2020
Customer
AiCuris
Site
Nijmegen
Department
Discovery
MCS People
Jasper Springer
Patent

paration of substituted sulfonyl triazoles and related heteroaryl compounds as as NLRP3 inhibitors usefulin treatment and prevention of diseases

Number
WO 2019/211463 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg, Jack den Hartog
Patent

Preparation of novel sulfonamide carboxamide compounds as NLRP3 inhibitors

Number
WO 2019/034696 A1WO 2019/034697 A1WO 2019/034686 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg
Patent

Preparation of sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

Number
WO 2019/008029 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg
Patent

Sulfonamide derivates as NLRP3 inhibitors and their preparation

Number
WO 2019/166633 A1
Year
2020
Customer
Inflamazone
Site
Groningen
Department
Discovery
MCS People
Jim van Wiltenburg
Patent

1,2,4-triazolederivatives as tankyrase inhibitors

Number
WO 2019/243822 A1
Year
2019
Customer
Oslo University
Site
Nijmegen
Department
Discovery
MCS People
Anita Wegert, Ruben Leenders
Patent

Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazole

Number
WO2019/197239 A1
Year
2019
Customer
Bayer Pharma
Site
Nijmegen
Department
Development
MCS People
Richard van der Haas, René Gieling

Scroll to top